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Abstract Curcumin, the yellow pigment of turmeric (Curcuma
longa), used commonly as a spice, has been shown to possess
anticarcinogenic activity. Curcumin inhibited AK-5 tumor
growth and induced apoptosis in AK-5 cells. Curcumin induced
apoptosis is mediated through the activation of caspase-3, which
is specifically inhibited by the tetrapeptide Ac-DEVD-CHO. In
addition, curcumin induced tumor cell death is caused through
the generation of reactive oxygen intermediates which is inhibited
by N-acetyl-L-cysteine. Our studies suggest that the apoptotic
process induced by curcumin is the mechanism mediating AK-5
tumor cell death.
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diene-3,5-dione], the active component of turmeric, a common
spice used in the Indian cuisine and routinely used in Indian
natural medicine [1], has been shown to exhibit antimutagenic
and anticarcinogenic activities in addition to the anti-in£am-
matory activity [2,3]. Curcumin has also been shown to pos-
sess bactericidal [4], anthelmintic activity and reduce choles-
terol levels when given orally [5]. Recently, curcumin has been
shown to induce apoptosis-like changes in rat thymocytes [6].
Curcumin has also been shown to inhibit cell proliferation
thus a¡ecting the cell cycle [7]. Several mechanisms for curcu-
min action, like inhibition of protein kinase C [8] and redox
regulation [9], have been proposed.
AK-5, a rat histiocytic tumor [10], is regressed when in-
jected s.c. but kills 100% of hosts when transplanted i.p.
[11]. Tumor cells are killed by necrosis and apoptosis [12].
In this paper, we have studied the antitumor activity of cur-
cumin in i.p. tumor transplanted animals. Eighty percent of
the animals transplanted with AK-5 cells did not develop
ascites after treatment with curcumin. Curcumin kills the tu-
mor cells by apoptosis, and induces typical apoptotic features
such as the formation of apoptotic bodies, DNA fragmenta-
tion in AK-5 tumor cells involving caspase-3 which is specif-
ically inhibited by the tetrapeptide DEVD-CHO. N-Acetylcys-
teine, an antioxidant, also inhibited curcumin mediated
apoptosis of AK-5 cells.
2. Materials and methods
2.1. Materials
AK-5 tumor was maintained as ascites in an inbred colony of Wis-
tar rats by injecting 5U106 tumor cells i.p. We also used a single cell
clone of AK-5 adapted to grow in vitro, called BC-8, in these studies
to avoid ambiguity in results due to tumor heterogeneity [13]. Dul-
becco’s modi¢ed Eagle’s medium (DMEM), fetal calf serum (FCS),
curcumin, and N-acetyl-L-cysteine were procured from Sigma Chem-
ical Co., USA. Propidium iodide was from Calbiochem, YVAD-AMC
and DEVD-AMC were purchased from Bachem, Switzerland and the
ECL detection kit was procured from Amersham, UK.
2.2. Apoptosis assay and £ow cytometry
BC-8 cells (1U106) were plated in DMEM-FCS. The cells were
incubated with 45% ammonium sulfate fraction of anti-AK-5 serum
called serum factor (10%) which served as the positive inducer of
apoptosis. Cells were treated with curcumin for di¡erent time periods.
After the incubation, the cells were washed with phosphate bu¡ered
saline, ¢xed in ethanol, and stained with propidium iodide (propidium
iodide 50 Wg/ml in 0.1% sodium citrate containing 0.1% Triton X-100)
and analyzed by £ow cytometry.
2.3. DNA extraction and electrophoresis
Fixed tumor cells were washed, suspended in citrate-phosphate
bu¡er and the fragmented DNA was extracted as described earlier
[14]. Fragmented DNA with loading bu¡er was electrophoresed on
0.8% agarose gel at 2 V/cm for 16 h. DNA in the gels was visualized
under UV light after staining with 5 Wg/ml ethidium bromide.
2.4. Inhibition of apoptosis
AK-5 or BC-8 cells (2U106) after treatment with curcumin (25 WM)
were extracted with lysis bu¡er. The cell extract was preincubated
with the tetrapeptide Ac-DEVD-CHO for 15 min and the extracts
were used for caspase assays.
2.5. Caspase assays
The activities of caspase-1 and caspase-3-like proteases were as-
sayed as described earlier [15]. Brie£y, 106 cells were lysed in lysis
bu¡er (1% Triton X-100, 0.32 M sucrose, 5 mM EDTA, 10 mM
Tris-HCl, pH 8.0, 2 mM DTT, 1 mM PMSF, 1 Wg/ml aprotinin
and 1 Wg/ml leupeptin) for 15 min at 4‡C followed by centrifugation
(20 000Ug) for 5 min. Caspase activities were detected in the super-
natants by measuring the proteolytic cleavage of the £uorogenic sub-
strates YVAD-AMC and DEVD-AMC [16] respectively in assay bu¡-
er (100 mM HEPES, 10% sucrose, 0.1% CHAPS, 2 mM DTT, 1 mM
PMSF, 1 Wg/ml each of aprotinin and leupeptin) using an excitation
wavelength of 380 nm and an emission wavelength of 460 nm.
2.6. Tumor growth
Ten animals in each group were transplanted with 2U106 AK-5
cells i.p. The curcumin group was administered 40 mg of curcumin
per rat/injection i.p. on days 0, 2, 4, 6, 8 and, 10 after tumor trans-
plantation. Animals were regularly monitored for the appearance of
peritoneal bulge and survival up to 40 days.
2.7. Inhibition of apoptosis by N-acetyl-L-cysteine
BC-8 cells (1U106) were cultured in DMEM-FCS in the presence of
curcumin (25 WM). Cells were also treated with di¡erent concentra-
tions of N-acetyl-L-cysteine (0.25^1 mM). After incubation the cells
were ¢xed, stained with propidium iodide and analyzed by £ow cy-
tometry.
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2.8. Western blotting
After treatment of AK-5 cells with curcumin, the cells were washed,
boiled in Laemmli’s sample bu¡er and the proteins were resolved by
SDS-PAGE, transferred onto nitrocellulose membrane and probed for
1 h with an appropriate dilution of antibody to PARP or caspase-3.
The blots were washed and treated with either alkaline phosphatase or
horseradish peroxidase-conjugated second antibody for 30 min. PARP
blot was developed for alkaline phosphatase and the caspase-3 blot
was developed with the ECL detection kit.
3. Results
3.1. E¡ect of curcumin on tumor growth
We have studied the e¡ect of curcumin on the growth of
AK-5 tumor as ascites. There was a signi¢cant inhibition of
tumor growth by curcumin (Table 1). All the control animals
developed peritoneal bulge and 90% of animals died by day
10. However, in curcumin treated animals, no peritoneal bulge
was observed in 80% of the animals and the animals survived
even after 40 days. These observations con¢rm the antitumor
activity of curcumin.
3.2. Curcumin induced apoptosis in AK-5 cells
In order to understand the exact mechanism of killing of
AK-5 tumor cells by curcumin, we incubated AK-5 cells with
di¡erent concentrations of curcumin in culture. Curcumin at
10 WM concentration induced apoptosis in about 40% of tu-
mor cells during 4 h incubation. The same concentration of
curcumin induced apoptosis in 100% of cells after 18 h incu-
bation. Induction of apoptosis was con¢rmed by the forma-
tion of apoptotic bodies (Fig. 1B) and fragmentation of cel-
lular DNA (Fig. 1C). Curcumin induced apoptosis was
quantitated by £ow cytometry after staining the cells with
propidium iodide. We also used a factor present in the serum
of tumor rejecting animals and dexamethasone as positive
inducers of apoptosis in AK-5 cells (data not shown).
3.3. Role of caspases in curcumin induced apoptosis
Caspases have been shown to participate in the execution
phase of the apoptotic process. After curcumin treatment of
AK-5 cells, we analyzed the cell extracts for caspase-1 and
caspase-3 activities using £uorogenic substrates. Caspase-1 ac-
tivity was not detected up to 12 h after curcumin treatment of
AK-5 cells, whereas caspase-3 activity was signi¢cantly higher
after 3 h curcumin treatment (Fig. 2). These results suggest
the participation of caspase-3 during curcumin induced apop-
tosis in AK-5 cells.
3.4. Speci¢c inhibition of caspase-3 activity
In order to con¢rm the participation of caspase-3 during
curcumin induced apoptosis in AK-5 cells, we used a caspase-
3 speci¢c tetrapeptide inhibitor Ac-DEVD-CHO (DEVD).
Caspase-3 activity was completely inhibited by 1 WM DEVD
(Fig. 3A). DEVD also inhibited the curcumin induced DNA
fragmentation in AK-5 cells (Fig. 1C, lanes 4 and 5). These
observations suggest caspase-3 to be a major cysteine protease
involved in curcumin induced apoptosis. Fig. 3B shows the
e¡ect of N-acetyl-L-cysteine on curcumin induced apoptosis in
AK-5 cells. A signi¢cant inhibition of apoptosis in tumor cells
was observed with N-acetyl-L-cysteine concentrations ranging
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Fig. 1. Curcumin induced formation of apoptotic bodies in AK-5
cells. A: Control cells. B: Curcumin treated propidium iodide
stained cells. C: Curcumin induced DNA fragmentation. Lanes 1,
control; 2, serum factor treated positive control; 3, 25 WM curcu-
min; 4, curcumin+DEVD 50 WM; 5, curcumin+DEVD 100 WM.
Fig. 2. Caspase-1 and caspase-3 activities in curcumin treated AK-5
cells at di¡erent time points. Caspase activities are expressed as rela-
tive £uorescence units.
Table 1
E¡ect of curcumin on the growth of AK-5 tumorsa
Group Number of animals dead/number
of animals injected
Control 9/10 (10%)
Curcumin treated 2/10 (80%)
aAK-5 tumor cells were transplanted i.p. Curcumin (40 mg/rat) was
administered i.p. on days 0, 2, 4, 6, 8, and 10 after the tumor trans-
plantation and the animals were monitored for tumor growth and
survival up to day 40. Control animals died by day 10 of AK-5 trans-
plantation. The values in parentheses denote percent survival.
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from 0.5 to 1.0 mM. These observations suggest the involve-
ment of reactive oxygen intermediates during curcumin medi-
ated apoptosis in AK-5 cells.
3.5. Activation of caspase-3
We also con¢rmed the cleavage of procaspase-3 to its active
form of 17 kDa by Western blotting (Fig. 4B, lane 3). Lane 2
is the serum factor treated tumor cells which acted as the
positive control. Similarly PARP was also degraded to its
cleavage product of 85 kDa (Fig. 4A, lane 3). Thus these
observations con¢rm participation of caspase-3 in curcumin
induced apoptosis in AK-5 cells.
4. Discussion
Immunological rejection of AK-5 tumor in syngeneic hosts
is mediated through necrosis and apoptosis [12] induced by
NK cells through perforin and granzyme B respectively [17].
AK-5 tumor cells transplanted i.p. are not rejected and kill
100% of hosts. This di¡erential response to the same tumor in
syngeneic animals has been ascribed to the overexpression of
interleukin-12 (p40 subunit) [18] and regulated expression of
Fas-L by the AK-5 cells transplanted i.p. which help the tu-
mor cells in immune escape [19]. In our studies curcumin was
highly e¡ective in inhibiting intraperitoneal tumor growth.
Therefore, it was interesting to study the mechanism of action
of curcumin on AK-5 tumor cells.
Curcumin, being a hydrophobic molecule [20], passes easily
through the plasma membrane into the cytosol. Recently cur-
cumin was shown to cause phosphatidylserine exposure, in-
creased plasma membrane permeability and decreased mito-
chondrial membrane potential and cell shrinkage [6], which
are typical features of apoptotic cells. In AK-5 cells too, cur-
cumin was able to induce the formation of apoptotic bodies
and fragmentation of nuclear DNA (Fig. 1). We excluded the
possibility of necrotic death in AK-5 cells induced after cur-
cumin treatment as there was no cell swelling and the mem-
brane remained intact at least during the initial phase of cur-
cumin treatment, which was further con¢rmed through the
involvement of caspase-3. However, caspase-1 does not seem
to be activated during curcumin induced apoptosis in AK-5
cells. Participation of caspase-3 was further con¢rmed using
DEVD as the speci¢c inhibitor which inhibited curcumin in-
duced apoptosis and fragmentation of AK-5 cell DNA.
Curcumin is a known antioxidant and acts as a scavenger of
free radicals [21]. Antioxidants such as superoxide dismutase
or catalase prevented curcumin induced apoptosis in human
leukemia cells [22]. We have recently shown the participation
of reactive nitrogen intermediates in AK-5 cell apoptosis [23]
and our preliminary observations indicate a role for reactive
oxygen intermediates during apoptosis (unpublished observa-
tions). This was further con¢rmed using N-acetyl-L-cysteine,
which is a well known scavenger of reactive oxygen intermedi-
ates, and inhibited curcumin induced apoptosis in AK-5 cells.
Similar observations were made during curcumin induced
apoptosis in human leukemic cells [22]. Curcumin also in-
creased the level of glutathione which would prevent thiol
depletion occurring during apoptosis [6]. Thus the role of
curcumin in redox balance needs further investigation. Curcu-
min is an interesting molecule because of the variety of bio-
logical e¡ects it possesses in addition to its potent anticancer
activity. However, its exact mechanism of action is not very
clear. Our present studies suggest that its anticancer activity
could be mainly due to its ability to induce apoptosis in tumor
cells.
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Fig. 4. Western blotting of PARP degradation (A) and caspase-3 ac-
tivation (B). Lanes 1, control AK-5 cells; 2, AK-5 cells+serum fac-
tor; 3, AK-5 cells+curcumin 25 WM.
Fig. 3. A: Inhibition of caspase-3 activity with di¡erent concentra-
tions of DEVD. 1, positive control; 2, DEVD 50 nM; 3, DEVD
100 nM; 4, DEVD 500 nM; 5, DEVD 1 WM. B: Inhibition of cur-
cumin induced apoptosis in AK-5 cells with di¡erent concentrations
of N-acetyl-L-cysteine (NAC). 1, control; 2, curcumin 25 WM; 3,
curcumin+NAC 0.25 mM; 4, curcumin+NAC 0.5 mM; 5, curcu-
min+NAC 0.75 mM; 6, curcumin+NAC 1 mM.
A. Khar et al./FEBS Letters 445 (1999) 165^168 167
References
[1] Nadkarni, K.M. (1976) in: Indian Materia Medica (Nadkarni,
K.M., Ed.), pp. 414^417, Popular Prakashan, Bombay.
[2] Stoner, G.D. and Mukhtar, H. (1995) J. Cell Biochem. Suppl. 22,
169^180.
[3] Kuttan, R., Bhanumathy, P., Nirmala, K. and George, M.C.
(1985) Cancer Lett. 29, 197^202.
[4] Ramprasad, C. and Sirsi, M. (1956) J. Sci. Ind. Res. (India) 156,
239^241.
[5] Pachuari, S.P. and Mukherjee, S.K. (1970) J. Res. Indian Med. 6,
27^31.
[6] Jaruga, E., Salvioli, S., Dobrucki, J., Chrul, S., Bandorowicz-
Pikula, J., Sickora, E., Franceschi, C., Cossarizza, A. and Bar-
tosz, G. (1998) FEBS Lett. 433, 287^293.
[7] Hanif, R., Qiao, L., Shi¡, S.J. and Rigas, B. (1997) J. Lab. Clin.
Med. 130, 576^584.
[8] Liu, J.-Y., Lin, S.-J. and Lin, J.-K. (1993) Carcinogenesis 14,
857^861.
[9] Pulla Reddy, A.Ch. and Lokesh, B.R. (1994) Food Chem. Tox-
icol. 32, 279^283.
[10] Khar, A. (1986) J. Natl. Cancer Inst. 76, 871^878.
[11] Khar, A. (1993) Int. J. Oncol. 2, 393^398.
[12] Kausalya, S., Hegde, S.P., Bright, J.J. and Khar, A. (1994) Exp.
Cell. Res. 212, 285^290.
[13] Khar, A. and Ali, A.M. (1990) In Vitro Cell. Dev. Biol. 26, 1024^
1025.
[14] Bright, J.J., Kausalya, S. and Khar, A. (1995) Immunology 85,
638^644.
[15] Dimmeler, B.S., Haendeler, J., Nehls, M. and Zeiher, A.M.
(1997) J. Exp. Med. 185, 601^607.
[16] Gurtu, V., Kain, S.R. and Zhang, G. (1997) Anal. Biochem. 251,
98^102.
[17] Khar, A., Pardhasaradhi, B.V.V., Varalakshmi, Ch., Ali, A.M.
and Kumari, A.L. (1997) Cell. Immunol. 177, 86^92.
[18] Nandakumar, K.S., Leelakumari, A. and Khar, A. (1997) Cyto-
kines Cell. Mol. Ther. 3, 225^232.
[19] Khar, A., Varalakshmi, Ch., Pardhasaradhi, B.V.V., Ali, A.M.
and Kumari, A.L. (1998) Cell. Immunol. 189, 85^91.
[20] Oetari, S., Sudibyo, M., Cammandeur, J.N.M., Samhoedi, R.
and Vermeulen, N.P.E. (1996) Biochem. Pharmacol. 51, 39^45.
[21] Tonnensen, H.H. and Greenhill, J.V. (1992) Int. J. Pharm. 87,
79^87.
[22] Kuo, M.-L., Huang, T.-S. and Lin, J.-K. (1996) Biochim. Bio-
phys. Acta 1317, 95^100.
[23] Bhaumik, S. and Khar, A. (1998) Apoptosis (in press).
FEBS 21585 22-2-99
A. Khar et al./FEBS Letters 445 (1999) 165^168168
